Pathological dissociation and neuropsychological functioning in borderline personality disorder

Acta Psychiatrica Scandinavica
V Ø Haaland, N I Landrø

Abstract

Transient, stress-related severe dissociative symptoms or paranoid ideation is one of the criteria defining the borderline personality disorder (BPD). Examinations of the neuropsychological correlates of BPD reveal various findings. The purpose of this study was to investigate the association between dissociation and neuropsychological functioning in patients with BPD. The performance on an extensive neuropsychological battery of patients with BPD with (n=10) and without (n=20) pathological dissociation was compared with that of healthy controls (n=30). Patients with pathological dissociation were found to have reduced functioning on every neuropsychological domain when compared with healthy controls. Patients without pathological dissociation were found to have reduced executive functioning, but no other differences were found. Pathological dissociation is a clinical variable that differentiates patients with BPD with regard to cognitive functioning.

References

Apr 1, 1977·Perceptual and Motor Skills·D M Gronwall
Jan 1, 1991·The American Journal of Psychiatry·K M O'LearyR W Cowdry
Nov 1, 1990·The American Journal of Psychiatry·C A RossR Currie
Dec 1, 1986·The Journal of Nervous and Mental Disease·E M Bernstein, F W Putnam
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
May 1, 1993·Journal of Clinical Psychology·T Swirsky-SacchettiB Burleigh
May 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·M Lund-JohansenK Wester
Nov 1, 1996·The Journal of Nervous and Mental Disease·F W PutnamB G Braun
Feb 1, 1997·Archives of General Psychiatry·J M GoldD R Weinberger
Jul 1, 1997·Comprehensive Psychiatry·C Zlotnick, T Pearlstein
Feb 21, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J H CallicottD R Weinberger
Dec 8, 1998·The American Journal of Psychiatry·M C ZanariniV Reynolds
Jan 5, 2000·Psychological Medicine·B JonesR S Jones
Jan 2, 2001·Journal of Clinical Psychology·J SprockC Y Yoder
Mar 22, 2001·British Journal of Clinical Pharmacology·S J de VisserJ M van Gerven
Mar 30, 2001·The Journal of Nervous and Mental Disease·M CimaK Kremer
Jun 14, 2002·Biological Psychiatry·Andrew E SkodolLarry J Siever
Jan 28, 2003·Behaviour Research and Therapy·Merel Kindt, Marcel van den Hout
Jun 13, 2003·Assessment·Joseph J Ryan, Summer D Schnakenberg-Ott
Jun 20, 2003·NeuroImage·Michiel B de RuiterRichard van Dyck
Jan 28, 2004·Journal of Personality Disorders·Hanns J KunertSabine C Herpertz
Mar 31, 2004·Psychiatry Research·Andreas StevensChristine Unckel
Aug 4, 2004·Lancet·Klaus LiebMartin Bohus
Sep 25, 2004·The Journal of Nervous and Mental Disease·Timo GiesbrechtEllen Smeets
Nov 4, 2004·Consciousness and Cognition·Michiel B de RuiterRichard van Dyck
Apr 22, 2005·British Journal of Clinical Pharmacology·G J H DumontUNKNOWN Biomarker Working Group of the German Association for Applied Human Pharmacology
Apr 15, 2006·Development and Psychopathology·Patricia Hoffman Judd
Apr 19, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jeannette LeGris, Rob van Reekum
May 25, 2007·Journal of the International Neuropsychological Society : JINS·Vegard Øksendal Haaland, Nils Inge Landrø
May 25, 2007·Psychotherapie, Psychosomatik, medizinische Psychologie·Diana BraakmannUlrich Schweiger
Jul 11, 2007·The Australian and New Zealand Journal of Psychiatry·Carsten SpitzerHans Joergen Grabe
Aug 11, 2007·Journal of Clinical and Experimental Neuropsychology·Amanda Schurle BruceRichard A Carlson
Dec 7, 2007·The American Journal of Psychiatry·David SilbersweigEmily Stern

❮ Previous
Next ❯

Citations

Jun 15, 2013·Psychiatry Research·Meike HagenhoffStefanie Lis
Jul 20, 2014·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Silvia Carvalho FernandoThomas Beblo
Aug 8, 2015·Human Psychopharmacology·Borwin Bandelow, Dirk Wedekind
May 29, 2012·Depression and Anxiety·Erika J WolfPaula P Schnurr
Jan 1, 2014·Journal of Trauma & Dissociation : the Official Journal of the International Society for the Study of Dissociation (ISSD)·Colin A RossElizabeth Schroeder
May 21, 2017·European Archives of Psychiatry and Clinical Neuroscience·Annegret Krause-UtzBernet M Elzinga
Mar 27, 2018·Current Behavioral Neuroscience Reports·Annegret Krause-Utz, Bernet Elzinga
Oct 11, 2011·Santé mentale au Québec·Suzane Renaud
Feb 1, 2017·Current Psychiatry Reports·Annegret Krause-UtzBernet M Elzinga
Apr 23, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Bahar KaplanHuseyin Gulec

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.